NasdaqGS - Nasdaq Real Time Price USD
Pacific Biosciences of California, Inc. (PACB)
1.0400
+0.0200
+(1.96%)
As of 12:53:16 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 10 | 12 |
| Avg. Estimate | -0.17 | -0.16 | -0.64 | -0.51 |
| Low Estimate | -0.18 | -0.17 | -0.68 | -0.62 |
| High Estimate | -0.14 | -0.13 | -0.59 | -0.38 |
| Year Ago EPS | -0.2 | -0.17 | -0.83 | -0.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 13 |
| Avg. Estimate | 36.35M | 39.71M | 155.64M | 186.94M |
| Low Estimate | 34M | 37.9M | 150.28M | 164.53M |
| High Estimate | 37.3M | 42M | 160.2M | 222.32M |
| Year Ago Sales | 36.01M | 39.97M | 154.01M | 155.64M |
| Sales Growth (year/est) | 0.94% | -0.64% | 1.06% | 20.11% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.21 | -0.17 | -0.19 |
| EPS Actual | -0.2 | -0.17 | -0.2 | -0.15 |
| Difference | 0.02 | 0.04 | -0.03 | 0.04 |
| Surprise % | 10.51% | 20.06% | -15.50% | 20.51% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.16 | -0.64 | -0.51 |
| 7 Days Ago | -0.18 | -0.18 | -0.71 | -0.57 |
| 30 Days Ago | -0.18 | -0.18 | -0.71 | -0.59 |
| 60 Days Ago | -0.19 | -0.18 | -0.73 | -0.59 |
| 90 Days Ago | -0.16 | -0.15 | -0.73 | -0.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 6 | 6 | 8 | 8 |
| Up Last 30 Days | 6 | 6 | 9 | 9 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PACB | 16.82% | 7.38% | 23.37% | 19.04% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Neutral to Neutral | 5/15/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 5/15/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 4/10/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/25/2025 |
| Reiterates | Piper Sandler: Neutral to Neutral | 2/20/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 2/18/2025 |
Related Tickers
QSI Quantum-Si incorporated
1.6750
+18.79%
CERS Cerus Corporation
1.2850
-2.65%
SENS Senseonics Holdings, Inc.
0.5203
-1.83%
BFLY Butterfly Network, Inc.
2.2900
-1.29%
QTRX Quanterix Corporation
5.03
+3.29%
NNOX Nano-X Imaging Ltd.
5.51
+0.46%
MASS 908 Devices Inc.
5.03
+5.35%
ALUR Allurion Technologies Inc.
3.1600
+3.27%
DXCM DexCom, Inc.
87.18
+0.26%
BIO Bio-Rad Laboratories, Inc.
247.03
-0.66%